Subscribe To
abbvie terminates deal with i-mab to develop cancer drug
China-based biotech company I-Mab said on Friday that abbvie has terminated a 2020 deal to co-develop a...
September 22, 2023, 5:09 pm
3 bargain stocks to buy in a market that's priced for perfection
abbvie is entering a new era but is well prepared to return to its winning ways. Gilead Sciences offers...
September 21, 2023, 1:54 pm
abbvie inc. (abbv) is attracting investor attention: here is what you should know
Zacks.com users have recently been watching abbvie (ABBV) quite a bit. Thus, it is worth knowing the fa...
September 18, 2023, 10:32 am
abbvie vs. astrazeneca: battle of the pharmaceutical behemoths
Currently, the S&P 500 and many sectors are outperforming the healthcare sector, presenting an opportunity to explore assets within this sector during...
September 15, 2023, 1:02 pm
2 dividend kings to buy on the dip and hold forever
Abbott Laboratories and abbvie used to be one and the same company. Both have raised their payouts for ...
September 15, 2023, 9:15 am
Novartis names new board member after international boss steps down
Novartis has appointed abbvie executive Patrick Horber to its executive committee, the Swiss pharmaceut...
September 6, 2023, 1:40 am
abbvie inc. (abbv) is a trending stock: facts to know before betting on it
Zacks.com users have recently been watching abbvie (ABBV) quite a bit. Thus, it is worth knowing the fa...
September 5, 2023, 10:31 am
abbvie unleashed: 4% yield, potentially 40% undervalued
abbvie has shown resilience and strength despite the patent loss of its best-selling drug, Humira. The ...
September 4, 2023, 8:19 am
abbvie: balance is everything
abbvie's future growth depends on improving its balance of drugs offered, in contrast to its Humira-dep...
September 4, 2023, 1:12 am
Ranking 5 dividend growth stocks from highest to lowest quality
The article ranks 5 dividend growth stocks based on their quality, focusing on factors such as balance sheet, management, growth, and stability. The H...
August 29, 2023, 9:48 am
Nearing retirement? these stocks will pay you for life
Drugmakers are often great dividend payers, and abbvie and Gilead are among the best. ...
August 29, 2023, 9:45 am
Merck, amgen, abbvie products among first 10 drugs selected for medicare price negotiations
Medicare on Tuesday announced the first 10 drugs selected for price negotiations, launching a historic and highly contentious process with big implica...
August 29, 2023, 7:50 am
3 surprisingly underrated stocks to buy right now
Investors aren't giving abbvie nearly enough credit for its post-Humira strategy. CRISPR Therapeutics' ...
August 26, 2023, 6:55 am
Investors heavily search abbvie inc. (abbv): here is what you need to know
Zacks.com users have recently been watching abbvie (ABBV) quite a bit. Thus, it is worth knowing the fa...
August 25, 2023, 10:31 am
Can abbvie (abbv) protect revenues after humira patent loss?
abbvie's (ABBV) newer products, Skyrizi and Rinvoq, are performing extremely well and have the potentia...
August 24, 2023, 12:01 pm
Cvs health launches biosimilars subsidiary, will commercialize humira competitor
CVS Health Corp. CVS, -0.97% said Wednesday that it has launched a new subsidiary that will work directly with drugmakers to co-produce and commercial...
August 23, 2023, 4:36 pm
abbvie: still a buy according to buffett's 10xebt rule
abbvie investors have good reason to be concerned about the company's future return potential. Sales ar...
August 23, 2023, 4:06 pm
abbvie (abbv) gets eu approval for migraine prevention drug
Following the approval, abbvie's (ABBV) Aquipta is the first and the only oral CGRP receptor antagonist...
August 17, 2023, 1:17 pm
Revance's botox rival gets fda approval for painful neck muscle condition
The U.S. health regulator has approved expanding the use of Revance Therapeutics' Daxxify to treat a painful neck muscle condition, intensifying the a...
August 14, 2023, 8:06 am
3 unstoppable dividend stocks to buy right now
abbvie is more unstoppable than you might think. Johnson & Johnson faces some challenges but remains a ...
August 12, 2023, 6:15 am